NCT05100069View on ClinicalTrials.gov

Survey of Brigatinib Used To Treat People With Non-Small Cell Lung Cancer

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

November 30, 2027

Study Completion Date

November 30, 2027

Conditions
Non-small Cell Lung Cancer (NSCLC)
Interventions
DRUG

Brigatinib

Brigatinib Tablets

Trial Locations (1)

Unknown

RECRUITING

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY